Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
作者信息
Dreyling M
机构信息
Department of Medicine III, University Hospital Grosshadern, LMU Munich, Germany.
出版信息
Ann Oncol. 2009 May;20 Suppl 4:119-20. doi: 10.1093/annonc/mdp148.
PMID:19454429
Abstract
摘要
相似文献
1
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2009 May;20 Suppl 4:119-20. doi: 10.1093/annonc/mdp148.
2
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2014 Sep;25 Suppl 3:iii76-82. doi: 10.1093/annonc/mdu200. Epub 2014 Aug 13.
3
Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2009 May;20 Suppl 4:21-3. doi: 10.1093/annonc/mdp117.
4
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.
5
Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2009 May;20 Suppl 4:108-9. doi: 10.1093/annonc/mdp144.
6
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.
Ann Oncol. 2003 Aug;14(8):1163-4. doi: 10.1093/annonc/mdg338.
7
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26.
8
Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2009 May;20 Suppl 4:113-4. doi: 10.1093/annonc/mdp146.
9
Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol. 2008 May;19 Suppl 2:ii77-8. doi: 10.1093/annonc/mdn096.
10
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2010 May;21 Suppl 5:v181-3. doi: 10.1093/annonc/mdq184.
引用本文的文献
1
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
Support Care Cancer. 2017 Mar;25(3):839-845. doi: 10.1007/s00520-016-3468-8. Epub 2016 Nov 3.
2
Inter-reader variability in follicular lymphoma grading: Conventional and digital reading.
J Pathol Inform. 2013 Oct 29;4:30. doi: 10.4103/2153-3539.120747. eCollection 2013.
3
Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy alone.
PLoS One. 2013 Jun 6;8(6):e65156. doi: 10.1371/journal.pone.0065156. Print 2013.
4
Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?
BMC Cancer. 2012 May 31;12:210. doi: 10.1186/1471-2407-12-210.
5
Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up.
Ann Oncol. 2011 May;22(5):1189-1197. doi: 10.1093/annonc/mdq582. Epub 2010 Dec 6.
6
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.
Clin Transl Oncol. 2010 Nov;12(11):760-4. doi: 10.1007/s12094-010-0592-7.
7
Bendamustine: a review of its use in the management of indolent non-Hodgkin's lymphoma and mantle cell lymphoma.
Drugs. 2010 Sep 10;70(13):1703-18. doi: 10.2165/11205860-000000000-00000.
Zotero 插件